Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | APAF1 | O14727 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.61 |
| ▸ | FDPS | P14324 | 17/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5288264 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL4266804 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5284351 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5286011 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5289982 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5301127 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5291994 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5290107 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5288678 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5282927 | 1.00 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9267214-B2 | Aluminum recovery process | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2016-02-23 | — | — | US | claimed |
| US-20110000782-A1 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2011-01-06 | — | — | US | claimed |
| WO-2009102419-A2 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2009-08-20 | — | — | WO | claimed |
| US-12291506-B2 | Method for producing amidate compound, and amidate compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-05-06 | — | — | US | disclosed |
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| CN-117043136-A | Fluorine-based ionic liquid and method for producing same | 第一工业制药株式会社 | 2023-11-10 | — | — | CN | disclosed |
| US-20230327207-A1 | Storage Battery, Battery Control Unit, and Electronic Device | SEMICONDUCTOR ENERGY LAB (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230231199-A1 | SECONDARY BATTERY AND VEHICLE INCLUDING SECONDARY BATTERY | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-07-20 | — | — | US | disclosed |
| WO-2022209538-A1 | FLUORINE-BASED IONIC LIQUID AND PRODUCTION METHOD THEREOF | 第一工業製薬株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-20220048864-A1 | METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2022-02-17 | — | — | US | disclosed |
| EP-3858817-A1 | METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND | Koei Chemical Company, Limited (JP) | 2021-08-04 | — | — | EP | disclosed |
| US-9267214-B2 | Aluminum recovery process | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150279577-A1 | POWER STORAGE DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20140134365-A1 | COVER TAPE | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2014-05-15 | — | — | US | disclosed |
| EP-2722290-A1 | COVER TAPE | Denki Kagaku Kogyo Kabushiki Kaisha (JP) | 2014-04-23 | — | — | EP | disclosed |
| US-20110000782-A1 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2011-01-06 | — | — | US | disclosed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | disclosed |
| WO-2009102419-A2 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2009-08-20 | — | — | WO | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12291506-B2 | Method for producing amidate compound, and amidate compound | NAAA, NIT2, PAM | MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885 |
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | VDAC3, VDAC2, SCO2 | MEN1 2332/4885HSP90AA1 2985/4885KMT2A 1910/4885 |
| US-20220048864-A1 | METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND | NAAA, NIT2, PAM | MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.